Mesenchymal Stem Cells for Progressive Multiple Sclerosis_Sweden

Summary

To assess the safety of a single dose of IV infusion of bone-marrow derived autologous Mesenchymal Stem Cells (MSCs) in Multiple Sclerosis (MS) with progressive disease status.

Timeline

Start

2012-12-01

Primary completion

2016-12

Completion

2016-12-31

Drugs

Indications